Coverart for item
The Resource Marketing of Clozaril : improved safety or barrier to access : hearing before the Subcommittee on Antitrust, Monopolies, and Business Rights of the Committee on the Judiciary, United States Senate, One Hundred Second Congress, first session, on the marketing of Clozaril, a drug for the treatment of schizophrenia, March 5, 1991

Marketing of Clozaril : improved safety or barrier to access : hearing before the Subcommittee on Antitrust, Monopolies, and Business Rights of the Committee on the Judiciary, United States Senate, One Hundred Second Congress, first session, on the marketing of Clozaril, a drug for the treatment of schizophrenia, March 5, 1991

Label
Marketing of Clozaril : improved safety or barrier to access : hearing before the Subcommittee on Antitrust, Monopolies, and Business Rights of the Committee on the Judiciary, United States Senate, One Hundred Second Congress, first session, on the marketing of Clozaril, a drug for the treatment of schizophrenia, March 5, 1991
Title
Marketing of Clozaril
Title remainder
improved safety or barrier to access : hearing before the Subcommittee on Antitrust, Monopolies, and Business Rights of the Committee on the Judiciary, United States Senate, One Hundred Second Congress, first session, on the marketing of Clozaril, a drug for the treatment of schizophrenia, March 5, 1991
Creator
Subject
Genre
Language
eng
Member of
Cataloging source
DGPO/DLC
Government publication
federal national government publication
Index
no index present
Literary form
non fiction
Nature of contents
bibliography
http://bibfra.me/vocab/lite/organizationName
United States
Series statement
S. hrg.
Series volume
102-175
http://library.link/vocab/subjectName
  • Sandoz Pharmaceuticals Corporation
  • Clozapine
  • Drugs
  • Antipsychotic drugs
  • Medical care
  • Schizophrenia
Label
Marketing of Clozaril : improved safety or barrier to access : hearing before the Subcommittee on Antitrust, Monopolies, and Business Rights of the Committee on the Judiciary, United States Senate, One Hundred Second Congress, first session, on the marketing of Clozaril, a drug for the treatment of schizophrenia, March 5, 1991
Instantiates
Publication
Note
  • Distributed to some depository libraries in microfiche
  • Shipping list no.: 91-660-P
  • "Serial no. J-102-6."
Bibliography note
Includes bibliographical references
Carrier category
volume
Carrier category code
  • nc
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Control code
24603103
Dimensions
24 cm
Extent
iii, 139 pages
Isbn
9780160354939
Lccn
91601788
Media category
unmediated
Media MARC source
rdamedia
Media type code
  • n
Label
Marketing of Clozaril : improved safety or barrier to access : hearing before the Subcommittee on Antitrust, Monopolies, and Business Rights of the Committee on the Judiciary, United States Senate, One Hundred Second Congress, first session, on the marketing of Clozaril, a drug for the treatment of schizophrenia, March 5, 1991
Publication
Note
  • Distributed to some depository libraries in microfiche
  • Shipping list no.: 91-660-P
  • "Serial no. J-102-6."
Bibliography note
Includes bibliographical references
Carrier category
volume
Carrier category code
  • nc
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Control code
24603103
Dimensions
24 cm
Extent
iii, 139 pages
Isbn
9780160354939
Lccn
91601788
Media category
unmediated
Media MARC source
rdamedia
Media type code
  • n

Library Locations

    • Leon E. Bloch Law LibraryBorrow it
      500 E. 52nd Street, Kansas City, MO, 64110, US
      39.032488 -94.581967
Processing Feedback ...